FLETCHER R JOHN 4
4 · ClearPoint Neuro, Inc. · Filed Apr 2, 2026
Research Summary
AI-generated summary of this filing
ClearPoint (CLPT) Director Fletcher R. John Receives 1,270-Share Award
What Happened
Fletcher R. John, a director of ClearPoint Neuro, received an award of 1,270 shares of ClearPoint common stock on April 1, 2026. The shares were issued at $9.10 each (the closing price on March 31, 2026), for a total value of $11,557. This transaction is coded as an award/grant (A) — a payment of fees, not an open-market purchase or sale.
Key Details
- Transaction date: 2026-04-01; Filing date: 2026-04-02 (timely; insiders typically must file within 2 business days).
- Price per share: $9.10; Total value: $11,557.
- Transaction type/code: Award/Grant (A) — issued as compensation.
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Footnote: Shares were issued under the issuer’s Sixth Amended and Restated 2013 Incentive Compensation Plan as payment for fees owed under the Non-Employee Director Compensation Plan, issued at the March 31, 2026 closing price.
Context
This was a director compensation award (stock issued in lieu of cash fees), which is a routine corporate practice and does not necessarily signal the director’s view of the stock. For investors tracking insider activity, purchases or open-market buys tend to carry more interpretive weight than compensatory awards.
Insider Transaction Report
- Award
Common Stock
[F1]2026-04-01$9.10/sh+1,270$11,557→ 117,932 total
Footnotes (1)
- [F1]These shares were issued pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at March 31, 2026.